Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No reply to my email sent to Mr. Kempers for a whole week.
Again two Form 4.
I would like to point to footnote (1) in the filings. The sales are not direct but indirect from Mr. Keen and Mr. Calton. The shares were held by a company called Carlton James Ltd. and obviously Mr. Calton and Mr. Keen control the shares through that company. Carlton James Ltd. seems to still own 26995986 shares. I can't believe they plan to sell that amount in parts of tenth or hunderd thousands.
I really like it.
Thanks. I have no Level 2.
Today I sent an email to Mr. Kempers. Didn't get a reply until now. I am curious if I will get one.
Kind of a little disappointing today.
Don't you trust the filings?
According to the OTCQB Certification from 10/28/2020
Keen: 99,923,283
Calton: 28,235,844
Dombrowski: 3,664,720
Kraft: 0
Hoffman: 0
But I don't know who owns how many stock options.
@Staypositive1: To line
1: leak
2: no
3: busy/regulation
But who knows... Today I was on the point to send an email to Mr. Kempers but that's probably waste of time.
I like it but can't believe this happens without news leaking.
Two Form 4 today. I don't understand it: Why do Victor Keen and Simon Calton sell some thousand shares in open market while owning many million shares? Are they cleaning up a bit, preparing for uplisting?
I doubt main investors are interested in pushing share price and dilluting their stake. We should never forget that they own the most shares and we are just crumbs.
And perhaps they think it's not necessary to raise a meaningful amount of money.
I wouldn't be surprised if we get significant news in February. Remember liquidation of Anergis and their intellectual property. Unfortunately I never saw a financial report from them, but they probably had a lot of debt. So, how could they liquidate the company without selling intellectual property? If there wouldn't be debt and there were only one or a few owners intellectual property could be easily transferred to that resp. theses persons. But creditors wouldn't accept that - they want to get their share.
If Anergis was a company as I suppose, they sold the birch pollen project. And that means for Mymetics
a) owns the IP now
b) licensed it's part on that project for instance to Stallergenes Greer and have a fat bank account now
c) will be sold
d) something strange happens, but I can't believe so.
In my opinion everything is well. In the shareholder letter one can read "In early 2021 evaluation samples of CHS will ship to customers. As we have reported, we have ten (10) initial evaluation samples [...]". That's a clear statement. They have the CHS produced and in hands; meanwhile it should been received by the customers.
One can also read "In fact, we have already asked Evonik for more CHS samples as demand has exceeded our initial expectations.". I think they wouldn't ask (and pay!) for more if Evonik couldn't produce big quantities.
I roughly doubled my share count recently.
Unfortunately without any information about financials:
https://www.otcmarkets.com/stock/ONPH/news/Oncology-Pharma-Extends-Its-Licensing-Agreement-with-NanoSmart-Pharmaceuticals-Inc-for-Human-Oncology?id=288565
I read a bit. It seems to me it's not possible to draw a conclusion from the timing of publicstions.
Debt holders of Anergis are asked to get in touch:
https://shab.ch/#!/search/publications/detail/ca34aad6-0517-44db-8572-c255f9faa903
https://shab.ch/#!/search/publications/detail/01d9a471-ff03-4b15-9605-576cd53ce84c
I would like to see their balance sheet to check intangible assets.
Unfortunately I am not familiar with Swiss regulations. Anergis is publishing the first and second call on two consecutive days. That could possibly mean that they have no debt holders left and that could mean they received "some" money, perhaps from a sale of intangible assets. - I am just guessing.
Thanks, the same to you.
I don't like shares to fall while I own them and I don't like chart analysis to predict share price in special with such small companies and volatile shares. But look at the chart: 0.08 is not a surprise. That looks just normal, nothing exciting. Nevertheless you are right that share price could go down further if there are no news since no news means no progress.
In my eyes there's nothing to be worried about today. Just one single trader being impatient can sell and bring price down. (I just checked the volume; the drop was because of 1500 shares - sometimes I find that quantity if I sweep up my office floor.)
Other things are more important in my opinion. In the Biopole story Mr. Kempers wrote: "[...] and three more are ongoing, including one at Bern University Hospital and another with Prof. T. Geiser and Dr. Amiq Gazdar at DBMR [...]". Why didn't he mention the third one? And why did he put time in that interview? He is a CEO and surely works conscientiously, and there's no audience he could direct that to - no customers and barely public interest. So, why spend that time?
I am just always looking for a reason.
No news as far as I can see.
Thanks for that link. Very interesting!
Also thanks to Mr. Kempers for that.
Thanks! I will send an email.
Some years ago I sent an email to dwalker@enableipc.com and got a detailed reply. But now the domain is used by a German SEO blog.
$36800 on bid, apparently without news.
Has anyone an email address to contact the company?
Thanks. I think life is currently everywhere just the same: Covid-19 all day long. It gets boring and annoying.
And on 13th of November (two weeks after Anergis' meeting) Mr. Kempers wrote: "[...] Anergis and Mymetics are currently in negotiation about a possible business relationship, but there is no assurance that this will be concluded."
Great! Looking forward to that.
I have been checking this every day now.
Just found, as of today: Anergis is on liquidation!
https://shab.ch/#!/search/publications/detail/872a72bd-af40-426d-9868-5b961638f8b9
They decided that on 29th of October! And no one tells us about that.
I am a bit angry now.
And what does that mean in regard of birch pollen... If the company is liquidated the birch pollen project would be an asset. Therefore they probably have sold the product.
Good, thanks. We really should get something from Mr. Kempers very soon. "Covid-19" is overdue and "birch pollen" apperntly were disposed in a publication.
Just in the news: Merck & Co failed in developing two Covid-19 vaccines.
Are we affected?
@Estrella: I only have a free account with no special functionality.
I am impressed: 0.0037, but I couldn't find anything new.
Mr. Kempers, you are the only one I can ask at biopole: Would you please go over to the office of Anergis, look through a window and tell us about what's going on there? Or perhaps did someone mention something in passing at the hot dog stand?
(Let's see, if my try works. )
I don't know, but that's surely market maker's action, not traders'. Perhaps there is a problem in their algorithms or something lies in front of us that makes them act.
Bid and Ask seem to be a bit crazy. Orders coming in and going out continuously.
I hope so. Waiting for this for almost 9 months.
Is finally something going on with EIPC, Mr. Walker?
Nothing for years and years.
Solrayo website ist gone, too.
There are also news regarding Anergis and Stallergenes at Mymetics' website: "Publication in "Clinical & Experimental Allergy""
https://www.mymetics.com/media-center/publication-national-center-biotechnology-information/
Anergis.ch is down the whole day. Perhaps because of an update?
Maria Elena Bottazzi at Twitter: "Much has happened since April and we are now at the brink of realizing our #COVID19 Global Health Vaccine in partnership with @biological_e"
I am curious about the influence on Mymetics.
Maria Elena Bottazzi at Twitter: "All I want for Christmas is a Vaccine".
I would like that as well!
I hope, there's no negative subtone in that message. It's not Santa's job to develop a vaccine.
Merry Christmas to all!
May your hard work be rewarded.
Thanks!
Then I would gladly wait for the 24th to get a nicely packaged buyout.
Shouldn't we have gotten news this month?
Only eight business days left.